HOME >> MEDICINE >> NEWS
Top NIH prize goes to three pioneering Stanford scientists

STANFORD, Calif. - For the second year in a row, three Stanford University School of Medicine researchers have snagged one of the National Institutes of Health's top prizes: the annual NIH Director's Pioneer Award. The prize provides each winner with $2.5 million over five years to pursue new research directions that are not already funded.

The 2006 recipients from Stanford are Kwabena Boahen, PhD; Karla Kirkegaard, PhD; and David Relman, MD. The 13 winners, selected from a pool of 465 applicants, will be announced by the NIH Sept. 19 in Bethesda, Md. With three winners, Stanford has more awardees this year than any other institution - and the most total since the award was established in 2004.

Philip Pizzo, MD, dean of the School of Medicine, welcomed the news. "I am pleased that since the program started two years ago, Stanford faculty have been selected for seven of the 34 Pioneer Awards, reflecting the excellence and innovative spirit of Stanford and our faculty," he said.

In each of the three years of the award's history, one of Stanford's winners has come from the Department of Bioengineering, which is jointly managed by the schools of engineering and of medicine.

"When Stanford founded its Department of Bioengineering four years ago we envisioned that it would be a place for the brightest minds in the field to tackle important problems at the intersection of the life sciences, medicine and engineering," said James D. Plummer, PhD, dean of the School of Engineering. "We are honored that NIH has recognized a member of our bioengineering faculty with this award for a third consecutive year."

The Pioneer Award funds scientists with creative ideas who propose novel approaches to major challenges in biomedical research. Ben Barres, MD, PhD, professor of neurobiology and of developmental biology at Stanford, served on the team that reviewed award applications and met with finalists this year as well as last year (he st
'"/>

Contact: Mitzi Baker
mabaker@stanford.edu
650-725-2106
Stanford University Medical Center
19-Sep-2006


Page: 1 2 3

Related medicine news :

1. Polish journalist scoops first prize in prestigious European award
2. MIT graduate student wins $30,000 Lemelson-MIT student prize for life-saving inventions
3. Karolinska Institutet prize for innovations in medical pedagogics
4. UCI epilepsy researcher receives nations top neuroscience prize
5. Daniel Zheng wins SIAMs first prize at INTEL-ISEF
6. Penn Scientist receives first annual prize for scientific contributions to womens health
7. Karen Duff receives prestigious prize for Alzheimers research
8. New TB test scoops top prize at Medical Futures competition
9. MRI pioneer wins national physics prize
10. Cancer researcher Susan Horwitz wins Alpert prize for Taxol work
11. UCI epilepsy researcher receives nations top neuroscience prize

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Top NIH prize goes three pioneering Stanford scientists

(Date:6/19/2013)... are increasingly common on college campuses, but are ... up"? A new study by researchers with The ... published online by the Archives of Sexual ... behaviors associated with sexual hookups, particularly among first-year ... negative emotional and physical health outcomes as a ...
(Date:6/19/2013)... the body,s system for repairing damage to the genetic ... as it may seem, those compounds are sparking optimism ... by a mutation in BRCA, a gene that made ... mutation. The compounds, termed PARP inhibitors, are the topic ... Chemical & Engineering News . C&EN is the ...
(Date:6/19/2013)... Moffitt Cancer Center and colleagues at Louisiana State University ... that require immediate therapy. It relies on understanding the ... is to better predict a prostate cancer,s aggressiveness to ... published in the online journal PLOS ONE ... accounts for 20 percent of all cancers and 9 ...
(Date:6/19/2013)... CA (PRWEB) June 19, 2013 Alternatives, ... permits some patients to quit using drugs while allowing ... Adi Jaffe, the founders of Alternatives, believe that abstinence-only ... before they enter treatment and that this approach hurts ... million people in the United States need treatment for ...
(Date:6/19/2013)... 2013 Many trying-to-conceive couples seek ... necessary, according to a recent study ... The results of this research confirm what Fairhaven ... decade – that trying-to-conceive women would benefit from ... body weight. Fairhaven Health is a leading provider ...
Breaking Medicine News(10 mins):Health News:Why are some college students more likely to 'hook up'? 2Health News:Moffitt Cancer Center researchers identify genetic variants predicting aggressive prostate cancers 2Health News:Top L.A. Addiction Experts Assert That an Abstinence-Only Approach to Addiction Keeps 85% of Addicts From Seeking Treatment 2Health News:Top L.A. Addiction Experts Assert That an Abstinence-Only Approach to Addiction Keeps 85% of Addicts From Seeking Treatment 3Health News:Fairhaven Health's Dr. Amos Grunebaum Says Fertility Awareness Leads to Babies 2Health News:Fairhaven Health's Dr. Amos Grunebaum Says Fertility Awareness Leads to Babies 3Health News:Fairhaven Health's Dr. Amos Grunebaum Says Fertility Awareness Leads to Babies 4
(Date:6/19/2013)... , June 19, 2013 The Physician-Patient Alliance for ... fatigue. The need to urgently address this issue ... Sentinel Event Alert #50 , "Medical device alarm safety in ... between January 2008 and June 2012, there were 98 alarm ... in death (82%) , 13 resulted in permanent loss ...
(Date:6/19/2013)... June 19, 2013   Voices Against Brain Cancer ... cure for brain cancer, today announced that it has ... support the clinical investigation of Toca 511 & Toca ... glioma brain cancer (Grade 3 or Grade 4).  Tocagen ... for advanced cancer, with an initial focus on brain ...
(Date:6/19/2013)... 2013   Nektar Therapeutics (Nasdaq: NKTR ... liability (HAL) study for NKTR-181, a first-in-class, opioid ... brain.  This slow rate of entry is designed to reduce ... addiction to current opioid analgesics. 1 In the study ... to placebo in "drug liking" and "feeling high" scores and ...
Breaking Medicine Technology:Three Lessons Learned to Reduce Alarm Fatigue and Improve Alarm Management and Patient Safety in Hospitals 2Three Lessons Learned to Reduce Alarm Fatigue and Improve Alarm Management and Patient Safety in Hospitals 3Voices Against Brain Cancer Awards Grant to Tocagen to Support Investigation of Toca 511 & Toca FC in Patients with Recurrent Brain Cancer 2Voices Against Brain Cancer Awards Grant to Tocagen to Support Investigation of Toca 511 & Toca FC in Patients with Recurrent Brain Cancer 3Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 2Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 3Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 4Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 5Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 6Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 7Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 8Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 9
Cached News: